184 related articles for article (PubMed ID: 18485915)
1. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer.
Kawamura YI; Toyota M; Kawashima R; Hagiwara T; Suzuki H; Imai K; Shinomura Y; Tokino T; Kannagi R; Dohi T
Gastroenterology; 2008 Jul; 135(1):142-151.e3. PubMed ID: 18485915
[TBL] [Abstract][Full Text] [Related]
2. Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation.
Aronica A; Avagliano L; Caretti A; Tosi D; Bulfamante GP; Trinchera M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3210-3220. PubMed ID: 27535614
[TBL] [Abstract][Full Text] [Related]
3. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation.
Kim YS; Deng G
Gastroenterology; 2008 Jul; 135(1):305-9. PubMed ID: 18558094
[No Abstract] [Full Text] [Related]
5. Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases.
Pucci M; Malagolini N; Dall'Olio F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919332
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
8. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract.
Groux-Degroote S; Wavelet C; Krzewinski-Recchi MA; Portier L; Mortuaire M; Mihalache A; Trinchera M; Delannoy P; Malagolini N; Chiricolo M; Dall'Olio F; Harduin-Lepers A
Int J Biochem Cell Biol; 2014 Aug; 53():442-9. PubMed ID: 24953560
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
Wang HR; Hsieh CY; Twu YC; Yu LC
Glycobiology; 2008 Jan; 18(1):104-13. PubMed ID: 17965433
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.
Chachadi VB; Cheng H; Klinkebiel D; Christman JK; Cheng PW
Int J Biochem Cell Biol; 2011 Apr; 43(4):586-93. PubMed ID: 21168523
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J
PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
16. Incomplete synthesis of the Sda/Cad blood group carbohydrate in gastrointestinal cancer.
Dohi T; Kawamura YI
Biochim Biophys Acta; 2008 Mar; 1780(3):467-71. PubMed ID: 17961927
[TBL] [Abstract][Full Text] [Related]
17. 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells.
Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R
Clin Epigenetics; 2021 Feb; 13(1):34. PubMed ID: 33579350
[TBL] [Abstract][Full Text] [Related]
18. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
19. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
20. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.
Lee A; Chick JM; Kolarich D; Haynes PA; Robertson GR; Tsoli M; Jankova L; Clarke SJ; Packer NH; Baker MS
Mol Cell Proteomics; 2011 Sep; 10(9):M900538MCP200. PubMed ID: 20167946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
